Application
C19orf29 Antibody (N-term) western blot analysis in MDA-MB435 cell line lysates (35ug/lane).This demonstrates the C19orf29 antibody detected the C19orf29 protein (arrow).Application
C19orf29 Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human cervix carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the C19orf29 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | C19orf29 Antibody (N-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | C19orf29; Uncharacterized protein C19orf29; Cactin; Renal carcinoma antigen NY-REN-24 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | C19orf29 |
|---|---|
| Alternative Names | C19orf29 Uncharacterized protein C19orf29 Cactin Renal carcinoma antigen NY-REN-24 |
| Molecular Weight(MW) | 88702 Da |
| Function | Involved in the regulation of innate immune response. Acts as negative regulator of Toll-like receptor and interferon- regulatory factor (IRF) signaling pathways. Contributes to the regulation of transcriptional activation of NF-kappa-B target genes in response to endogenous proinflammatory stimuli. May play a role during early embryonic development. Probably involved in pre-mRNA splicing |
| Tissue Specificity | This C19orf29 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 219-248 amino acids from the N-terminal region of human C19orf29. |
| Cellular Localization | Nucleus. Note=Nuclear localization with a speckled expression pattern in some cells. Colocalizes with NFKBIL1 in the nucleus |
| Entrez Gene | 58509 |
|---|---|
| Nucleotide Accession | NP_067054.1 |
Application
C19orf29 Antibody (N-term) western blot analysis in MDA-MB435 cell line lysates (35ug/lane).This demonstrates the C19orf29 antibody detected the C19orf29 protein (arrow).
Application
C19orf29 Antibody (N-term) immunohistochemistry analysis in formalin fixed and paraffin embedded human cervix carcinoma followed by peroxidase conjugation of the secondary antibody and DAB staining. This data demonstrates the use of the C19orf29 Antibody (N-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
